312 related articles for article (PubMed ID: 34777330)
1. Highly Purified Alloantigen-Specific Tregs From Healthy and Chronic Kidney Disease Patients Can Be Long-Term Expanded, Maintaining a Suppressive Phenotype and Function in the Presence of Inflammatory Cytokines.
Cortés-Hernández A; Alvarez-Salazar EK; Arteaga-Cruz S; Rosas-Cortina K; Linares N; Alberú Gómez JM; Soldevila G
Front Immunol; 2021; 12():686530. PubMed ID: 34777330
[TBL] [Abstract][Full Text] [Related]
2. Large-Scale Generation of Human Allospecific Induced Tregs With Functional Stability for Use in Immunotherapy in Transplantation.
Alvarez-Salazar EK; Cortés-Hernández A; Arteaga-Cruz S; Alberú-Gómez J; Soldevila G
Front Immunol; 2020; 11():375. PubMed ID: 32300340
[TBL] [Abstract][Full Text] [Related]
3. Natural regulatory T cells from patients with end-stage renal disease can be used for large-scale generation of highly suppressive alloantigen-specific Tregs.
Litjens NH; Boer K; Zuijderwijk JM; Klepper M; Peeters AM; Verschoor W; Kraaijeveld R; Betjes MG
Kidney Int; 2017 May; 91(5):1203-1213. PubMed ID: 27988212
[TBL] [Abstract][Full Text] [Related]
4. Highly purified and functionally stable
Arteaga-Cruz S; Cortés-Hernández A; Alvarez-Salazar EK; Rosas-Cortina K; Aguilera-Sandoval C; Morales-Buenrostro LE; Alberú-Gómez JM; Soldevila G
Front Immunol; 2023; 14():1062456. PubMed ID: 36911743
[TBL] [Abstract][Full Text] [Related]
5. CD4+CD25+CD127-Foxp3+ and CD8+CD28- Tregs in Renal Transplant Recipients: Phenotypic Patterns, Association With Immunosuppressive Drugs, and Interaction With Effector CD8+ T Cells and CD19+IL-10+ Bregs.
Aly MG; Ibrahim EH; Karakizlis H; Weimer R; Opelz G; Morath C; Zeier M; Ekpoom N; Daniel V
Front Immunol; 2021; 12():716559. PubMed ID: 34335631
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic Mature Human Dendritic Cells Generate Superior Alloreactive Regulatory T Cells in the Presence of IL-15.
Litjens NH; Boer K; Zuijderwijk JM; Klepper M; Peeters AM; Prens EP; Verschoor W; Kraaijeveld R; Ozgur Z; van den Hout-van Vroonhoven MC; van IJcken WF; Baan CC; Betjes MG
J Immunol; 2015 Jun; 194(11):5282-93. PubMed ID: 25917092
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly.
Veerapathran A; Pidala J; Beato F; Yu XZ; Anasetti C
Blood; 2011 Nov; 118(20):5671-80. PubMed ID: 21948174
[TBL] [Abstract][Full Text] [Related]
8. Generation and Characterization of Alloantigen-Specific Regulatory T Cells For Clinical Transplant Tolerance.
Mathew JM; Voss JH; McEwen ST; Konieczna I; Chakraborty A; Huang X; He J; Gallon L; Kornbluth RS; Leventhal JR
Sci Rep; 2018 Jan; 8(1):1136. PubMed ID: 29348660
[TBL] [Abstract][Full Text] [Related]
9. Reduced frequency and functional defects of CD4
Luo L; Zeng X; Huang Z; Luo S; Qin L; Li S
Reprod Biol Endocrinol; 2020 Jun; 18(1):62. PubMed ID: 32522204
[TBL] [Abstract][Full Text] [Related]
10. Adoptive transfer of CD4+CD25+ regulatory cells combined with low-dose sirolimus and anti-thymocyte globulin delays acute rejection of renal allografts in Cynomolgus monkeys.
Ma A; Qi S; Song L; Hu Y; Dun H; Massicotte E; Dupuis M; Daloze P; Chen H
Int Immunopharmacol; 2011 May; 11(5):618-29. PubMed ID: 21094689
[TBL] [Abstract][Full Text] [Related]
11. Low-dose IL-2 expands CD4
Li Y; Liu X; Wang W; Wang S; Zhang J; Jiang S; Wang Y; Li L; Li J; Zhang Y; Huang H
Ren Fail; 2018 Nov; 40(1):280-288. PubMed ID: 29619880
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.
Zeng M; Guinet E; Nouri-Shirazi M
Transpl Immunol; 2009 Dec; 22(1-2):82-92. PubMed ID: 19635560
[TBL] [Abstract][Full Text] [Related]
13. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.
Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A
Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487
[TBL] [Abstract][Full Text] [Related]
14. Low expressions of PD-L1 and CTLA-4 by induced CD4
Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
[TBL] [Abstract][Full Text] [Related]
15. Alloantigen specific T regulatory cells in transplant tolerance.
Hall BM; Tran G; Hodgkinson SJ
Int Immunopharmacol; 2009 May; 9(5):570-4. PubMed ID: 19539571
[TBL] [Abstract][Full Text] [Related]
16. Requirements for prolongation of allograft survival with regulatory T cell infusion in lymphosufficient hosts.
Brennan TV; Tang Q; Liu FC; Hoang V; Bi M; Bluestone JA; Kang SM
J Surg Res; 2011 Jul; 169(1):e69-75. PubMed ID: 21571317
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of regulatory T cells expanded ex vivo from cord blood and adult peripheral blood.
Fan H; Yang J; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Gao F; Liu M
Immunology; 2012 Jun; 136(2):218-30. PubMed ID: 22348606
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid hormone differentially modulates the in vitro expansion and cytokine profile of thymic and splenic Treg cells.
Pap R; Ugor E; Litvai T; Prenek L; Najbauer J; Németh P; Berki T
Immunobiology; 2019 Mar; 224(2):285-295. PubMed ID: 30612787
[TBL] [Abstract][Full Text] [Related]
19. The imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients.
Ma L; Zhang H; Hu K; Lv G; Fu Y; Ayana DA; Zhao P; Jiang Y
BMC Immunol; 2015 Sep; 16():56. PubMed ID: 26400627
[TBL] [Abstract][Full Text] [Related]
20. Expansion of human regulatory T-cells from patients with type 1 diabetes.
Putnam AL; Brusko TM; Lee MR; Liu W; Szot GL; Ghosh T; Atkinson MA; Bluestone JA
Diabetes; 2009 Mar; 58(3):652-62. PubMed ID: 19074986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
